Begin main content

CADTH pan-Canadian Oncology Drug Review

The pan-Canadian Oncology Drug Review (pCODR) is an evidence-based, cancer drug review process.

The pCODR process is designed to bring consistency and clarity to the assessment of cancer drugs by reviewing clinical evidence, cost-effectiveness, and patient perspectives, and using this information to make recommendations to Canada's provinces and territories (except Quebec) in guiding their drug funding decisions.

Drug Review Updates

Neratinib (Nerlynx) for Hormone Receptor-Positive Breast Cancer
(Open for Input on Submission until May 3, 2019)

Trastuzumab (Brand Name: TBD) for Breast and Gastric Cancer Biosimilar
(Pending Submission as of April 16, 2019)

Dinutuximab (Unituxin) for Neuroblastoma
(Notification to Implement Issued as of April 10, 2019)

Enzalutamide (Xtandi) for Non-Metastatic Castration-Resistant Prostate Cancer
(Notification to Implement Issued as of April 10, 2019)

RFA: Bosutinib (Bosulif) for Chronic Myeloid Leukemia
(Open for Input on Request for Advice until April 23, 2019)

Enasidenib (Idhifa) for Acute Myeloid Leukemia
(Open for Input on Submission until April 22, 2019)

Venetoclax (Venclexta) in combo Rituximab for Chronic Lymphocytic Leukemia
(Open for Feedback on Recommendation until April 18, 2019)

Dacomitinib (Vizimpro) for Non-Small Cell Lung Cancer
(Open for Feedback on Recommendation until April 18, 2019)

Pembrolizumab (Keytruda) for Non-Squamous Non-Small Cell Lung Cancer
(Open for Feedback on Recommendation until April 18, 2019)

Blinatumomab (Blincyto) for Philadelphia Chromosome Positive B-cell Precursor Acute Lymphoblastic Leukemia
(Final Recommendation Issued as of April 4, 2019)

Pralatrexate (Folotyn) for Peripheral T-Cell Lymphoma
(Final Recommendation Issued as of April 4, 2019)

Olaparib (Lynparza) for Newly Diagnosed Ovarian Cancer
(Pending Submission as of March 21, 2019)

Rituximab (Brand Name: TBD) for Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia Biosimilar
(Pending Submission as of March 20, 2019)

 

Find a Drug Review